Is Coca-Cola Europacific Partners (CCEP) Outperforming Other Consumer Staples Stocks This Year?
For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Coca-Cola European (CCEP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.
Coca-Cola European is one of 178 companies in the Consumer Staples group. The Consumer Staples group currently sits at #11 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Coca-Cola European is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for CCEP's full-year earnings has moved 4.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, CCEP has gained about 19.2% so far this year. In comparison, Consumer Staples companies have returned an average of 7.4%. As we can see, Coca-Cola European is performing better than its sector in the calendar year.
Another Consumer Staples stock, which has outperformed the sector so far this year, is BJ's Wholesale Club (BJ). The stock has returned 25% year-to-date.
For BJ's Wholesale Club, the consensus EPS estimate for the current year has increased 1.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Coca-Cola European is a member of the Beverages - Soft drinks industry, which includes 16 individual companies and currently sits at #36 in the Zacks Industry Rank. Stocks in this group have gained about 8.3% so far this year, so CCEP is performing better this group in terms of year-to-date returns.
In contrast, BJ's Wholesale Club falls under the Consumer Products - Staples industry. Currently, this industry has 38 stocks and is ranked #144. Since the beginning of the year, the industry has moved +1.8%.
Coca-Cola European and BJ's Wholesale Club could continue their solid performance, so investors interested in Consumer Staples stocks should continue to pay close attention to these stocks.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Coca-Cola Europacific Partners (CCEP) : Free Stock Analysis Report
BJ's Wholesale Club Holdings, Inc. (BJ) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time. AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmaceutical companies in the world. AstraZeneca was formed on Apr 6, 1999, through the merger of Sweden's Astra AB and UK's Zeneca Group plc. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include CVRM (cardiovascular, renal and metabolism), Respiratory & Immunology (R&I), Oncology, Rare Diseases, Vaccines and Other. AZN sits at a Zacks Rank #3 (Hold), holds a Growth Style Score of B, and has a VGM Score of A. Earnings and sales are forecasted to increase 9.3% and 6.7% year-over-year, respectively. Two analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0 to $4.49 per share. AZN also boasts an average earnings surprise of 4.2%. On a historic basis, Astrazeneca has generated cash flow growth of 18.6%, and is expected to report cash flow expansion of 16.7% this year. Investors should take the time to consider AZN for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 hours ago
- Yahoo
Is PepsiCo Still a Refreshing Buy?
Sales growth has been anemic. The board of directors recently increased the dividend by 5%. The share price drop has created a better valuation. 10 stocks we like better than PepsiCo › PepsiCo (NASDAQ: PEP) has become a household name. In fact, it's likely you have at least one of the company's products in your home right now. However, investors need to consider more than the ubiquity of a company's product before purchasing the stock. You should analyze a company's prospects before committing to an investment. It's particularly imperative when the shares have dropped by quite a bit. In the case of PepsiCo, the stock has fallen about 23% over the last year through June 3. It's time to take a closer look at PepsiCo to see if the market has overreacted to short-term concerns or whether the drop is foretelling long-term issues. PepsiCo sells its beverages and food items under brands like Pepsi, Gatorade, and Quaker. However, even this large consumer staples company isn't immune from larger economic forces. First-quarter revenue only grew about 1% compared to a year ago. Price increases contributed 3 percentage points but lower volume subtracted 2 percentage points. The company adjusted these figures to exclude foreign-currency translation effects and the impact of acquisitions and divestitures. On an adjusted basis, operating profitability dropped 1%. Certainly, those numbers aren't very encouraging, and volume has been weak for some time. Investors would like to see higher volume driving faster revenue growth. However, it's important to remember that consumers have been weary from persistently high inflation that has squeezed their wallets, and tariffs add another level of uncertainty. Management noted the economic challenges when projecting a low-single-digit percentage increase in revenue this year and flat earnings per share compared to 2024. However, these short-term global economic factors don't change my optimistic view about PepsiCo's long-term prospects given its powerful brands. At some point, prices will stabilize and people will return to their more normal purchasing habits. When they do, it's hard to imagine they won't reach for a bottle of soda or chips sold under PepsiCo's umbrella. If you like dividends, PepsiCo fits the bill. In fact, the company has built quite a track record. The board of directors raised the company's quarterly dividend by 5%, starting in June. The new quarterly rate is $1.4225, or $5.69 annually. It's also a strong indication of management's and the board's confidence in PepsiCo's future. Impressively, that marked 53 consecutive years with a dividend increase. That makes PepsiCo a Dividend King, which is a group of companies that have raised payouts for at least 50 years. At the new annual dividend rate, the stock has a 4.3% dividend yield. That's much higher than the S&P 500 index's 1.3%. Aside from its impressive track record and recent increase, PepsiCo can afford the dividends when looking at objective measures like the 78% payout ratio. PepsiCo's sharp stock decline has resulted in a better valuation. Its price-to-earnings (P/E) ratio has fallen from 27 to 19. Of course, tepid sales and earnings growth will drive down a stock price and P/E ratio. While PepsiCo may never achieve rapid growth, the company should see a higher pace of revenue and earnings gains when broader economic policies return to a more normal state and consumers feel more comfortable spending money. What should investors do? While investors looking for pure growth stocks may find better alternatives, if you're interested in dividends, PepsiCo makes a good choice. That's based on the stock's attractive yield and commitment to regular increases. Additionally, patient investors should benefit from a higher share price. The prospect of an attractive total return adds up to a buying opportunity for those willing to wait for better economic times. Before you buy stock in PepsiCo, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and PepsiCo wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Is PepsiCo Still a Refreshing Buy? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
19 hours ago
- Yahoo
Lemonade (LMND) Reports Q1 Earnings: What Key Metrics Have to Say
Lemonade (LMND) reported $151.2 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 27%. EPS of -$0.86 for the same period compares to -$0.67 a year ago. The reported revenue represents a surprise of +5.05% over the Zacks Consensus Estimate of $143.93 million. With the consensus EPS estimate being -$0.94, the EPS surprise was +8.51%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Lemonade performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: In force premium (end of period): $1.01 billion compared to the $999.35 million average estimate based on four analysts. Premium per Customer (end of period): $396 versus $394.15 estimated by four analysts on average. Customers (end of period): 2,545,496 versus the four-analyst average estimate of 2,535,658. Net loss ratio: 82% versus the four-analyst average estimate of 89%. Gross loss ratio: 78% compared to the 80.8% average estimate based on four analysts. Net investment income: $9.50 million versus the four-analyst average estimate of $8.45 million. The reported number represents a year-over-year change of +25%. Ceding commission income: $26.90 million versus $22.06 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +28.1% change. Commission income: $10.50 million versus the four-analyst average estimate of $8.02 million. The reported number represents a year-over-year change of +72.1%. Net earned premium: $104.30 million compared to the $105.18 million average estimate based on four analysts. The reported number represents a change of +23.6% year over year. View all Key Company Metrics for Lemonade here>>>Shares of Lemonade have returned +6.7% over the past month versus the Zacks S&P 500 composite's +11.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lemonade, Inc. (LMND) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
